Drug Interactions: When Medicines Collide

Two roads to trouble

A drug interaction happens when one drug changes how another behaves. They come in two flavours. Pharmacokinetic interactions change how much drug reaches the target — one drug alters the absorption, distribution, metabolism, or excretion of the other, so its blood level rises or falls. Pharmacodynamic interactions leave levels alone but change the effect — two drugs that do the same thing add up, or two that oppose cancel out.

Pharmacodynamic interactions are intuitive. Two CNS depressants — say a benzodiazepine plus alcohol — both push sedation, and together they can stop breathing. An agonist and its antagonist given together just blunt each other. The dangerous, sneaky interactions are usually the pharmacokinetic ones, because the drug that causes the harm may not be the drug whose level changed.

The CYP engine room

Most pharmacokinetic interactions run through the liver's cytochrome P450 enzymes, especially the workhorse CYP3A4, which metabolizes roughly half of all drugs. Two opposite events matter. An inhibitor blocks the enzyme, so a drug it normally clears piles up — that is enzyme inhibition, and it raises levels fast, sometimes within a day. An inducer makes the body build more enzyme, so the drug is cleared faster and levels fall — that is enzyme induction, which takes a week or two to develop and to wear off.

DRUG A (the perpetrator)        DRUG B (the victim, a CYP3A4 substrate)

Inhibitor of CYP3A4
  e.g. clarithromycin, azoles  ->  B not cleared  ->  B level UP  ->  toxicity

Inducer of CYP3A4
  e.g. rifampicin, carbamazepine -> B cleared faster -> B level DOWN -> failure

Classic casualty: an oral contraceptive failing because
rifampicin induced its metabolism -> unplanned pregnancy.

Inhibitors raise the victim drug fast; inducers lower it slowly. Both can be disastrous.

Who gets hurt, and how to stay safe

Interactions matter most for drugs with a narrow therapeutic window, where a small level shift crosses into harm. The classic victim is warfarin, an anticoagulant: dozens of inhibitors raise its level and trigger bleeding, while inducers drop it and let clots form. Another old mechanism is drug displacement from plasma protein binding — one drug bumps another off albumin, briefly raising the free, active fraction.

Keep one full, current medication list — including supplements, herbals, and over-the-counter drugs.
Flag narrow-window drugs (warfarin, digoxin, lithium, many immunosuppressants) for extra scrutiny.
When adding or stopping a CYP inhibitor/inducer, anticipate the level shift and monitor or adjust the dose.